Search research articles
Contact Us
Filters
Showing results (351-360 of 471) with videos related to
Page
of 48
Sort By:
Blood Cancer Journal
|
August 30, 2020
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
Ashley Paquin, Alissa Visram, Shaji K Kumar, et al.
Blood Advances
|
April 13, 2019
Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis
Mohammed A Aljama, M Hasib Sidiqi, Angela Dispenzieri, et al.
Leukemia
|
September 28, 2018
Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio
Eli Muchtar, Angela Dispenzieri, Nelson Leung, et al.
Blood
|
June 22, 2011
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease
Martha Q Lacy, Jacob B Allred, Morie A Gertz, et al.
Acta Haematologica
|
June 8, 2026
Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies
Maymona Abdelgamid, Naima J Hashi, Mehrdad Hefazi, et al.
Blood Advances
|
March 3, 2019
Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma
Nidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings
|
February 17, 2019
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing
Eli Muchtar, Morie A Gertz, Robert A Kyle, et al.
Leukemia
|
October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United States
Moritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
American Journal of Hematology
|
March 18, 2017
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis
Nidhi Tandon, Surbhi Sidana, Morie A Gertz, et al.
Blood Advances
|
February 17, 2021
Prognostic restaging after treatment initiation in patients with AL amyloidosis
Nadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Page
of 48
Search research articles
Search
Showing results (351-360 of 471) with videos related to
Sort By:
Page
of 48
Blood Cancer Journal
|
August 30, 2020
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
Ashley Paquin, Alissa Visram, Shaji K Kumar, et al.
Blood Advances
|
April 13, 2019
Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis
Mohammed A Aljama, M Hasib Sidiqi, Angela Dispenzieri, et al.
Leukemia
|
September 28, 2018
Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio
Eli Muchtar, Angela Dispenzieri, Nelson Leung, et al.
Blood
|
June 22, 2011
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease
Martha Q Lacy, Jacob B Allred, Morie A Gertz, et al.
Acta Haematologica
|
June 8, 2026
Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies
Maymona Abdelgamid, Naima J Hashi, Mehrdad Hefazi, et al.
Blood Advances
|
March 3, 2019
Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma
Nidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings
|
February 17, 2019
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing
Eli Muchtar, Morie A Gertz, Robert A Kyle, et al.
Leukemia
|
October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United States
Moritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
American Journal of Hematology
|
March 18, 2017
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis
Nidhi Tandon, Surbhi Sidana, Morie A Gertz, et al.
Blood Advances
|
February 17, 2021
Prognostic restaging after treatment initiation in patients with AL amyloidosis
Nadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Page
of 48